Healthcare
American Heart Association Launches Initiative to Accelerate Aortic Stenosis Diagnosis and Clinical Trial Access
The American Heart Association has launched a new initiative to improve early diagnosis of aortic stenosis and increase participation in clinical trials, potentially transforming care for this serious heart condition that often goes undiagnosed until advanced stages.
NanoViricides to Present Broad-Spectrum Antiviral Pipeline at Spartan Capital Investor Conference
NanoViricides will present its clinical-stage antiviral drug pipeline at the Spartan Capital Investor Conference, highlighting the potential significance of its platform technology for treating multiple viral diseases including RSV, COVID-19, influenza, and other respiratory infections.
LogicMark CEO Outlines Growth Strategy Through Personal Safety Innovation
LogicMark CEO Chia-Lin Simmons discusses the company's SaaS model and innovation-driven growth strategy in the personal emergency response systems market, highlighting how technology is transforming safety solutions for at-risk populations.
LogicMark CEO Discusses Connected Care Platform for At-Risk Populations
LogicMark CEO Chia-Lin Simmons detailed the company's comprehensive medical safety device offerings for seniors across all care levels during a recent interview, highlighting the importance of connected care technology for vulnerable populations.
Cybin Secures $175 Million in Funding to Advance Mental Health Therapeutics
Cybin Inc. has closed a $175 million registered direct offering with top healthcare investors, providing critical capital to advance its Phase 3 clinical programs for novel mental health treatments addressing major depressive disorder and generalized anxiety disorder.
Cybin Chief Medical Officer to Present at Prestigious 2025 Milken Institute Health Summit
Cybin Inc.'s Chief Medical Officer will participate in the 2025 Milken Institute Future of Health Summit, highlighting the company's advanced clinical-stage mental health treatments and their potential to address significant unmet medical needs.
GeoVax Relocates Headquarters and Labs to Atlanta Area to Fuel Growth and Pipeline Advancement
GeoVax Labs is relocating its corporate headquarters and laboratory operations to new Atlanta-area facilities, positioning the clinical-stage biotechnology company for accelerated growth, late-stage development, and future commercialization of its cancer and infectious disease therapies.
Maryland Faces Health Insurance Challenges as Federal Tax Credits Expire and New Rules Take Effect
Maryland residents confront significant health insurance changes including premium increases due to expiring federal tax credits, new restrictions on DACA recipients, and upcoming enrollment deadline reductions that could impact coverage for hundreds of thousands of people.
Maryland Residents Face Potential Health Care Premium Hikes as Subsidy Deadline Nears
Over 180,000 Maryland residents could experience significant health care premium increases if Congress fails to extend enhanced Obamacare subsidies before Saturday's deadline.
ABVC BioPharma Reports 230% Licensing Revenue Growth and Major Asset Expansion in Q3 2025
ABVC BioPharma achieved significant financial growth with 230% year-over-year licensing revenue increase and 181% asset expansion, driven by strategic investments in Taiwan manufacturing facilities that strengthen the company's global dual-core operational structure.
Quick Bystander CPR Within Five Minutes Nearly Doubles Pediatric Cardiac Arrest Survival
New research shows that initiating CPR within five minutes of a child's cardiac arrest can nearly double survival rates, highlighting the critical importance of immediate bystander intervention for pediatric emergencies.
Optimal Cardiovascular Health May Offset Dementia Risk in Type 2 Diabetes Patients
New research suggests that maintaining optimal cardiovascular health through the American Heart Association's Life's Essential 8 metrics can significantly reduce the risk of cognitive decline and dementia in people with Type 2 diabetes, even for those with high genetic risk.
Hidden Atrial Dysfunction Identified as Stroke Risk Factor in Heart Muscle Disease Patients
A new study reveals that people with transthyretin amyloid cardiomyopathy face significantly higher stroke risk when they have atrial electromechanical dysfunction, and researchers have developed a noninvasive assessment tool to identify those who might benefit from preventive treatments.
Long-Term Melatonin Use Linked to Increased Heart Failure Risk in Insomnia Patients, Study Finds
A preliminary study suggests adults with insomnia who used melatonin supplements for at least one year had significantly higher rates of heart failure diagnosis, hospitalization and death compared to non-users, raising important safety concerns about the widely available sleep aid.
Combining Healthy Lifestyle Habits with GLP-1 Medications Reduces Cardiovascular Risk in Type 2 Diabetes Patients
A study of over 63,000 veterans with Type 2 diabetes found that combining GLP-1 receptor agonist medications with at least six healthy lifestyle habits reduced cardiovascular event risk by 50% compared to standard care alone.
Combined Biomarker Analysis Reveals Triple Heart Attack Risk in High-Risk Individuals
A new study shows that analyzing three specific biomarkers together can identify individuals with nearly triple the risk of heart attack, potentially enabling earlier intervention and personalized prevention strategies.
Low-Dose Aspirin Shows Cardiovascular Benefits for High-Risk Type 2 Diabetes Patients
A preliminary study suggests adults with Type 2 diabetes and moderate-to-high cardiovascular risk who take low-dose aspirin experience significantly lower rates of heart attack, stroke, and death compared to non-users, though bleeding risks require careful consideration.
AI Tool Detects Structural Heart Disease Using Smartwatch ECG Sensors
An artificial intelligence algorithm paired with smartwatch ECG sensors can accurately detect structural heart diseases, potentially making early screening more accessible to millions of people who already own these devices.
Pediatrician Dr. Carolyn Whitney Earns Second National Top 50 Health Professional Recognition
Dr. Carolyn Whitney's repeated recognition as one of the nation's top health professionals highlights the enduring importance of patient-centered care and clinical excellence in an era increasingly focused on healthcare metrics.
Quantum BioPharma Announces Private Placement to Strengthen Voting Control and Fund Operations
Quantum BioPharma Ltd. is conducting a $750 private placement that will significantly increase voting control for its key executives while providing working capital for its neurodegenerative and metabolic disorder treatments.
Cybin Secures $175 Million in Registered Direct Offering to Advance Mental Health Treatments
Cybin Inc. has raised $175 million through a registered direct offering, providing crucial funding to advance its late-stage clinical trials for novel mental health treatments including CYB003 for major depressive disorder and CYB004 for generalized anxiety disorder.
Lifordi Immunotherapeutics Advances Glucocorticoid ADC LFD-200 into Phase 1 Rheumatoid Arthritis Trial Following Promising Nonclinical Data
Lifordi Immunotherapeutics has initiated Phase 1 clinical trials for LFD-200, a novel antibody-drug conjugate that delivers glucocorticoids directly to immune cells, potentially overcoming the systemic toxicity limitations that have restricted steroid use in autoimmune diseases for decades.
HUSK Introduces Custom Wellness Challenge Platform to Address Evolving Workplace Health Needs
HUSK has launched a new wellness challenge platform that helps employers build sustainable health cultures by motivating employees through customizable physical activity, mindfulness, and nutrition challenges.
DC Domestic Violence Organization Deploys Wearable Safety Technology for Staff Protection
My Sister's Place, Washington DC's oldest domestic violence organization, has partnered with Silent Beacon to equip staff with wearable safety devices that can discreetly alert emergency services and share GPS location during high-risk situations.
LogicMark Advances Medical Alert Technology with Video Check-In Capabilities
LogicMark Inc. is expanding the capabilities of medical alert systems with innovative products like the Freedom Alert Max, which features video check-in functionality and represents the company's push for continued growth in the senior care technology market.
LogicMark Expands AI-Driven Safety Platform to Capture Growing $147 Billion Market
LogicMark Inc. is leveraging artificial intelligence and a Software-as-a-Service model to transform personal emergency response systems, enabling real-time monitoring for aging adults while positioning the company for recurring revenue streams in the rapidly expanding smart safety market.
New Book Offers Biblical Guidance for Cancer Survivors Navigating Post-Treatment Life
Author Theresia Whitfield's new book "After Cancer: Now What?" provides biblical guidance and practical support for cancer survivors facing the emotional and spiritual challenges of life after treatment.
Federal Funding Changes Threaten Rural Healthcare Access Amid Existing Health Disparities
Recent federal healthcare funding changes are expected to disproportionately impact rural communities that already face significant health challenges and limited access to care.
Oncotelic Therapeutics to Present Novel Breast Cancer Treatment Data at 2025 Symposium
Oncotelic Therapeutics will present clinical data for its investigational breast cancer treatment Sapu003 at the 2025 San Antonio Breast Cancer Symposium, potentially offering improved efficacy and reduced toxicity for patients with HR⁺/HER2⁻ metastatic breast cancer.
American Heart Association Launches National Initiative to Improve Pulmonary Embolism Care
The American Heart Association is launching a three-year quality improvement initiative to address critical gaps in pulmonary embolism diagnosis, treatment and follow-up care, targeting a condition that kills about one in five high-risk patients and represents the third leading cause of cardiovascular death in the U.S.